Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a digital assistant and quick tests stop unnecessary antibiotics for kids?

NCT ID NCT05050825

Diagnosis Sponsor: Foundation for Innovative New Diagnostics, Switzerland Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 16, 2026 · Last updated Sep 17, 2026 · Updated 1 time

Summary

Researchers in Senegal are testing a new way to care for children under 15 who come to primary health clinics with fever or diarrhea. The strategy combines rapid tests for malaria, dengue, and strep A with a digital tool that suggests treatment based on symptoms and test results. The trial compares this approach to usual care to see if it safely reduces antibiotic prescriptions while children still recover by day 7.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A clinical decision support algorithm combined with rapid diagnostic tests for malaria, dengue, and strep A
What this could lead to
If it works, this strategy could help doctors prescribe antibiotics more wisely for children in places where many fevers have viral or parasitic causes.
What could go wrong
The digital tool may not fit busy clinics, rapid tests can miss infections, and the trial may not show that the strategy is as safe as usual care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

470 people

The number who actually took part.

Started

May 2021

Finished

Dec 2021

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 months to 15 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Ongoing fever or diarrhea * ongoing fever will be defined objectively or as a reported fever, defined as : axillary temperature ≥37.5°C or tympanic, oral or rectal temperature ≥38.0°C; and fever duration ≤ 10 days * ongoing diarrhea will be defined as at least 3 abnormal stools during the last 24hrs * First consultation for the current illness * Feasibility of contact between the patient (or his/her designated relative) and the study team at day 3 and day 7 * Written informed consent by the caretaker/legally acceptable representative Exclusion Criteria: * Infants less than 6 months of age * Age ≥ 15 years * Clinical status requiring immediate transfer to an appropriate care facility/ severe illness

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute diarrhea are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute diarrhea dengue disease diarrheal disease malaria pneumonia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute febrile illness Dengue Diarrhea Influenza -like illness Malaria Pneumonia

Contacts and locations

Locations

  • PS Kedougou-Dalaba

    Kedougou, Senegal

  • PS Mbour-Toucouleur

    Mbour, Senegal

  • PS Ndiaye-Fatick

    Fatick, Senegal

  • PS Pont-Tambacounda

    Tambacounda, Senegal

More trials for these conditions

Other studies related to the condition(s) this trial covers.